Physician profile
Jacquelin Walters
NPI 1285628891
$147,469.39
in general payments reported to CMS, 2019-2025
21 companies · $146K in 2025
The $146K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $181 · 2021: $234 · 2022: $212 · 2023: $138 · 2024: $117 · 2025: $146K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $146K · Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $146,114.00 |
| Food and Beverage | $475.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $146,194.05 | 2021-2025 | Nexplanon |
| Abbvie INC. | $332.31 | 2019-2024 | Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $140.82 | 2019-2025 | |
| Astellas Pharma US INC | $121.53 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $98.48 | 2022 | |
| Hologic Sales and Service, LLC | $87.41 | 2019-2023 | Aptima |
| Therapeuticsmd, INC. | $65.84 | 2019-2020 | |
| Avion Pharmaceuticals | $64.60 | 2019-2023 | Balcoltra |
| Lupin INC. | $60.96 | 2019-2021 | |
| Becton, Dickinson and Company | $45.61 | 2022-2025 | Arista |
| Mayne Pharma Commercial LLC | $43.16 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.69 | 2019-2020 | |
| Exeltis, USA INC. | $32.85 | 2019-2020 | |
| Pfizer INC. | $26.86 | 2025 | |
| Dexcom, INC. | $22.72 | 2025 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $19.53 | 2024 | Wallach Cryosurgical Equipment |
| Evofem Biosciences, INC. | $19.49 | 2021 | |
| Millicent US INC | $18.63 | 2025 | Femlyv, Intrarosa |
| Mylan Pharmaceuticals INC. | $15.54 | 2020 | |
| Dysis Medical, INC. | $12.79 | 2020 | |
| Allergan, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelin Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.